2023-06-30
Today June 30 marks the last day of the Swedish Presidency of the European Council where antibiotic resistance was successfully lifted to the top of the health policy agenda. ReAct looks back at our efforts to place antibiotic resistance on the presidency agenda and what was achieved over the last six months.
Back when Sweden last held the presidency in 2009, ReAct played a central role in placing antibiotic resistance on the presidency agenda, and a conference on antibiotic Research & Development was organized which today is still considered as a milestone in antibiotic Research & Development policy discussions.
Swedish Presidency instrumental to advance global antibiotic resistance efforts
Against this background, ReAct was keen to ensure that the Swedish Presidency this time was also instrumental for making advances on global efforts to address antibiotic resistance, global governance discussions and well taking stock of antibiotic Research & Development.
ReAct engagement and report
ReAct started engaging with relevant ministries two years ago following the publication of our report on “Ensuring sustainable access to effective antibiotics for everyone, everywhere” which outlines how governments can take an end-to-end approach to antibiotic Research & Development.
EU High-level Meeting on AMR
ReAct was therefore particularly pleased to see the high-level meeting on AMR organized by the Swedish Presidency and the preceding expert meeting on antibiotic Research & Development highlighting the end-to-end approach.
ReAct participated in both meetings and was pleased to provide support for the development of background documents, as well as the “Golden R&D and Access chain” which was presented by the Swedish Presidency at the expert meeting and the subsequent High-Level meeting.
Central findings from the meeting and potential solutions proposed, such as milestone prizes, research coordination and conditionalities on research funding, are likely now to be assessed further within the newly established European ‘Health Emergency and Response Agency’, HERA.
EC published two key documents
At the end of April the European Commission published two key documents relevant for antimicrobial resistance:
- the new proposal for pharmaceutical legislation which addresses new incentives for antibiotic Research & Development and
- a proposal for Council Conclusions on antimicrobial resistance.
While the legislative process on the pharmaceutical legislation will be ongoing for a number of months to come, the Council recommendations were negotiated at remarkable speed and was adopted at the June Ministerial meeting of Health ministers in Brussels.
These recommendations included – for the first time – landmark EU- and country-level targets for reductions of antibiotic consumption as well as targets for reducing a number of resistant bacterial infections.
Specific mention of ReAct
Moreover, the Council recommendations included a specific mention of ReAct, as one of a few central players to engage and support, in the EU’s global work to help addressing antimicrobial resistance in low- and middle-income countries.
High-level conference in Uppsala
Finally, in early May, ReAct organized a high-level conference on “Unlocking barriers for collective action on antibiotic resistance” in collaboration with Uppsala University, supported by the Beijer Foundation and the Swedish Research Council, and held within the framework of the Swedish Presidency.
On the second day of the conference the Swedish Minister of Health, Mr. Jacob Forssmed opened discussions with a keynote speech. This three-day conference brought together participant from more than 20 countries across the world. The meeting report with summary of discussions and central recommendations will be forthcoming after the summer.
More from "2023"
- New ReAct Brief: Antibiotic resistance is one of the greatest & most urgent cross-border health crises of our time – but still not addressed as such!
- 3 questions to MSF: Antimicrobial resistance in the ongoing Gaza war
- ReAct reports from the first AMR Multi-stakeholder Partnership Platform Plenary Assembly
- Workshop on community engagement on antibiotic resistance
- ReAct Asia Pacific: Youth engagement in India
- ReAct highlights World AMR Awareness Week 2023
- Latin America Empowered Communities: One Health meeting with diverse and hopeful voices
- Zambia: March for treatable infections during World AMR Awareness Week
- Release ReAct Africa Conference Report
- ReAct activities for World AMR Awareness Week 2023
- Join React Latin America Empowered Communities Meeting Series in November!
- Join ReAct webinar! AMR High-level Meeting 2024: Mobilizing Collective Action
- ReAct Report: Unlocking Barriers for Collective Action
- 5 reasons why the European Transferable Exclusivity Voucher proposal should go in the bin
- Alforja Educativa launched in Brazil!
- ReAct Asia Pacific: Engaging youth on AMR
- Antibiotic smart students and Teachers
- Key takeaways from the ReAct Africa & South Centre Conference 2023
- ART, BACTERIA AND THE MICROBIOME – A book launch in Ecuador
- Community engagement series – education and advocacy materials!
- Student Kyembe Ignitius Salachi
- ReAct is hiring! Are you our new Director for ReAct Asia Pacific?
- Strengthening Diagnostics Capacity: How can the newly adopted resolution help to contain the spread of antibiotic resistance?
- Almedalen 2023
- Join international dialogue on Art, Microbes and Planetary Health!
- Key achievements on antibiotic resistance during the Swedish EU Council Presidency
- ReAct Africa Conference 2023
- 3 reason why a new Pandemic Accord should address antibiotic resistance
- ReAct’s Impact Report 2019-2022!
- Ambitious new AMR recommendations adopted by EU Member States today
- 33rd ECCMID – ReAct’s highlights and impressions
- Uppsala Dialogue meeting: Experts from more than 20 countries gathered for collaborative actions on ABR
- ReAct Asia Pacific: Sensitizing civil society in India
- Sweden: International high-level meeting – unlocking barriers for collective action on antibiotic resistance
- Sweden’s successful approach to antibiotic resistance can be used as inspiration in other countries
- When Doctor Rianto suffered from antibiotic resistance as a patient
- ReAct Latin America: Cycling as community engagement
- Statement by ReAct – in response to the EC adoption of the revised pharmaceutical legislation proposal
- Mitigating AMR using implementation research: a development funder’s approach
- High-level conference in Japan: Universal Health Coverage, pandemic prevention, preparedness & response and AMR in focus
- New UNEP report – spotlight on environment and AMR
- New publication! Equitable access to antibiotics: A core element for pandemic preparedness and response
- Sustainable access to effective antibiotics in focus at Swedish EU presidency High-level meeting
- New ReAct Expert Policy Brief: 5 key challenges and public not-for-profit solutions in early stages antibiotics R&D
- Time is ticking – more needs to be done to tackle antibiotic resistance
- Sweden: Towards an antibiotic smart society
- Lancet article: Transferable exclusivity voucher: A flawed incentive to stimulate antibiotic innovation
- Lancet article: An analysis of existing national action plans for antimicrobial resistance – gaps and opportunities in strategies optimising antibiotic use in human populations
- New experts in the ReAct Toolbox Advisory Group!
- Dancing with bacteria: a theatrical performance about antibiotic resistance
- Malin Grape – Sweden’s AMR Ambassador on her role and the Swedish EU Presidency
- Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance
- Dr. Jaya Ranjalkar new Director ReAct Asia Pacific